Filing Details
- Accession Number:
- 0001022079-18-000090
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-06 19:41:42
- Reporting Period:
- 2018-03-02
- Accepted Time:
- 2018-03-06 19:41:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1222679 | E Michael Prevoznik | 500 Plaza Drive Secaucus NJ 07094 | Svp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-03-02 | 8,134 | $101.00 | 47,900 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2018-03-02 | 4,006 | $101.00 | 43,899 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2018-03-05 | 4,128 | $101.00 | 39,771 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,895 | Indirect | 401(k)/SDCP |
Footnotes
- Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 23, 2015, approved in accordance with the requirements of Rule 16b-3(d).
- Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.
- The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
- The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 29, 2016.
- These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
Billionaire Hedge Funds
